Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,492 | -2,850 | -1,545 | -456 | -7,279 |
| Depreciation Amortization | 203 | 150 | 92 | 45 | 186 |
| Accounts payable and accrued liabilities | 450 | -843 | -821 | -592 | -2,076 |
| Other Working Capital | 808 | -1,078 | -1,125 | -710 | -4,332 |
| Other Operating Activity | 19,375 | 32 | -123 | -265 | -866 |
| Operating Cash Flow | $-5,656 | $-4,589 | $-3,522 | $-1,978 | $-14,367 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9 | -14 | -9 | 2 | 2 |
| PPE Investments | -3 | 6 | -2 | N/A | N/A |
| Sale Of Investment | 458 | 610 | 290 | 219 | 187 |
| Other Investing Activity | 186 | 134 | 85 | 36 | 320 |
| Investing Cash Flow | $632 | $736 | $364 | $257 | $509 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,393 | 7,135 | 664 | 221 | 7,837 |
| Other Financing Activity | -1,060 | -1,099 | -195 | -118 | -1,063 |
| Financing Cash Flow | $6,333 | $6,036 | $469 | $103 | $6,774 |
| Exchange Rate Effect | 7 | 8 | 24 | -11 | -4 |
| Beginning Cash Position | 7,401 | 7,401 | 7,401 | 7,401 | 14,489 |
| End Cash Position | 8,717 | 9,592 | 4,736 | 5,772 | 7,401 |
| Net Cash Flow | $1,316 | $2,191 | $-2,665 | $-1,629 | $-7,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,656 | -4,589 | -3,522 | -1,978 | -14,367 |
| Capital Expenditure | -3 | 6 | -2 | N/A | N/A |
| Free Cash Flow | -5,659 | -4,583 | -3,524 | -1,978 | -14,367 |